Loading...

ADC Therapeutics S.A.

ADCT•NYSE
Healthcare
Biotechnology
$3.86
$0.10(2.66%)
U.S. Market opens in 14h 43m

ADC Therapeutics S.A. (ADCT) Stock Overview

Explore ADC Therapeutics S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap489.7M
P/E Ratio-4.45
EPS (TTM)$-0.97
ROE0.65%
Fundamental Analysis

AI Price Forecasts

1 Month$4.06
3 Months$4.98
1 Year Target$3.95

ADCT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ADC Therapeutics S.A. (ADCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.72, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.45 and a market capitalization of 489.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.53%
5-Day Change
1.98%
1-Month Change
5.04%
3-Month Change
-3.87%
6-Month Change
-7.33%
Year-to-Date (YTD) Change
9.21%
1-Year Change
198.84%
3-Year Change
81.84%
5-Year Change
-82.95%
All-Time (Max) Change
-87.00%

Contact Information

https://www.adctherapeutics.com
41 21 653 02 00
Biopole, Epalinges, NaN, 1066

Company Facts

263 Employees
IPO DateMay 18, 2020
CountryCH
Actively Trading

Frequently Asked Questions